Inhibitors
Inhibitors are molecules that bind to enzymes, receptors, or other proteins to reduce or block their biological activity. These compounds are widely used in research to study biological pathways, understand disease mechanisms, and develop therapeutic drugs. Inhibitors play a crucial role in the treatment of various diseases, including cancer, cardiovascular diseases, and infections. At CymitQuimica, we provide a diverse range of high-quality inhibitors to support your research in biochemistry, cell biology, and pharmaceutical development.
Subcategories of "Inhibitors"
- Angiogenesis(2,763 products)
- Apoptosis(6,207 products)
- Cell Cycle/Checkpoint(4,810 products)
- Chromatin/Epigenetics(2,547 products)
- Cytoskeletal Signaling(1,520 products)
- DNA Damage/DNA Repair(2,908 products)
- Endocrinology/Hormones(3,703 products)
- Enzyme(3,671 products)
- GPCR/G-Protein(9,002 products)
- Immunology and Inflammation(3,751 products)
- Influenza Virus(298 products)
- JAK/STAT signaling(416 products)
- MAPK Signaling(1,245 products)
- Membrane Transporter/Ion Channel(3,103 products)
- Metabolism(10,129 products)
- Microbiology/Virology(7,570 products)
- Neuroscience(10,343 products)
- Other Inhibitors(35,810 products)
- Oxidation-Reduction(40 products)
- PI3K/Akt/mTOR Signaling(1,412 products)
- Proteases/Proteasome(1,682 products)
- Stem Cell and Derivatives(757 products)
- Tyrosine Kinase/Adaptors(1,954 products)
- Ubiquitination(1,715 products)
Show 16 more subcategories
Found 66606 products of "Inhibitors"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Casein Kinase II Inhibitor IV Hydrochloride
CAS:Casein Kinase II Inhibitor IV HCl promotes keratinocyte differentiation, potential for skin disorder therapy.Formula:C24H24ClN5O3Purity:98%Color and Shape:SolidMolecular weight:465.93Antiviral agent 15
Compound 15f, a Clofazimine derivative, inhibits rabies (EC50: 1.45 μM) and SARS-CoV-2 (EC50: 14.6 μM).Formula:C27H24FN5OColor and Shape:SolidMolecular weight:453.51LRRK2-IN-2
CAS:LRRK2-IN-2: selective, potent LRRK2 inhibitor, IC50 of 0.6 nM, oral, crosses blood-brain barrier, for Parkinson's research.Formula:C23H23Cl2F3N6O2Color and Shape:SolidMolecular weight:543.37[D-Leu-4]-OB3
CAS:[D-Leu-4]-OB3 suppresses the expression of genes associated with inflammation, proliferation, and metastasis, as well as the expression of PD-L1.Formula:C29H50N8O12SColor and Shape:SolidMolecular weight:734.82FXIa-IN-8
FXIa-IN-8: potent FXIa blocker (IC50: 14.2 nM), anti-thrombotic, low bleeding/toxicity risk.Color and Shape:SolidHuman carbonic anhydrase II-IN-1
Compound S-13: Potent hCA II inhibitor, Kis 4.4, 9.2, 480.2, 14.7 nM for hCA II, I, IV, IX. Used in glaucoma research.Formula:C20H25N3O4SColor and Shape:SolidMolecular weight:403.5LY210073
CAS:LY210073 is an antagonist of the Leukotriene B4 (LTB4) receptor (IC50: 6.2 nM).Formula:C30H28O8Purity:98%Color and Shape:SolidMolecular weight:516.54IACS-8779
CAS:IACS-8779 is a potent STING agonist that efficiently stimulates interferon gene activity and exhibits strong systemic antitumor effects.Formula:C21H25N9O10P2S2Purity:98%Color and Shape:SolidMolecular weight:689.55BMS-681
CAS:BMS-681 is a CCR2 antagonist blocking chemokine binding, aiding control of inflammatory and neurodegenerative diseases.Formula:C26H36F3N5OColor and Shape:SolidMolecular weight:491.59TAS-117 hydrochloride
TAS-117 HCl: potent oral Akt inhibitor (Akt1 IC50: 4.8nM, Akt2: 1.6nM, Akt3: 44nM), boosts anti-myeloma effects, induces cell death.Formula:C26H25ClN4O2Color and Shape:SolidMolecular weight:460.96Antitubulin agent 1
Antitubulin agents-1 disrupts microtubules, ups α-tubulin acetylation, and has anticancer properties.Formula:C21H19N3O3Color and Shape:SolidMolecular weight:361.39FT001
CAS:FT001: Oral BET Bromodomain inhibitor, IC50=0.46μM, suppresses MYC, anti-cancer, effective in vitro/vivo.Formula:C25H29N3O4SPurity:99.9%Color and Shape:SolidMolecular weight:467.58Ref: TM-T27392
1mg115.00€2mg172.00€5mg255.00€10mg374.00€25mg562.00€50mg787.00€100mg1,074.00€500mg2,147.00€1mL*10mM (DMSO)299.00€Anti-inflammatory agent 19
Anti-inflammatory agent 19: NO inhibitor (IC50: 36μM), blocks HMGB1, for late-stage inflammation, relevant for COVID-19, sepsis.Formula:C30H50O7Color and Shape:SolidMolecular weight:522.71HBV-IN-12
CAS:HBV-IN-12: strong HBsAg & HBV DNA inhibitor; EC50 0.001-0.05 μM & 0.001-0.02 μM respectively. (WO2021204252A1)Formula:C23H27NO8Color and Shape:SolidMolecular weight:445.46BTK inhibitor 18
BTK inhibitor 18 is a selective, potent, covalent, orally active Btk inhibitor (IC50: 142 nM) that exhibits anti-inflammatory effects.Formula:C29H25N5O4S2Color and Shape:SolidMolecular weight:571.675(S),6(S)-DiHETE
CAS:5(S),6(S)-DiHETE: a 5,6-dihydroxy acid from LTA4 hydrolysis, lacks leukotriene activity.Formula:C20H32O4Color and Shape:SolidMolecular weight:336.47RMS5
CAS:RMS5: hambanine analogue, inhibits P-gp, anti-cancer with cytotoxic, anti-proliferative effects, reduces Bcl-2 proteins, cleaves PARP.Formula:C35H38N2O5SColor and Shape:SolidMolecular weight:598.756-trans-12-epi-Leukotriene B4
CAS:6-trans-12-epi-Leukotriene B4, a metabolite of arachidonic acid, serves as a potent anti-inflammatory agent.Formula:C20H32O4Color and Shape:SolidMolecular weight:336.47FGFR3-IN-4
CAS:FGFR3-IN-4 is a selective inhibitor targeting FGFR3, demonstrating an IC50 value of under 50 nM.Formula:C26H24ClN7OColor and Shape:SolidMolecular weight:485.97PDHK-IN-3
PDHK-IN-3 (compound 7) is a potent inhibitor of pyruvate dehydrogenase kinase(PDHK) with IC50s of 0.21 and 1.54 μM for PDHK2 and PDHK4, respectively [1].Formula:C17H16N2O2Color and Shape:SolidMolecular weight:280.32
![[D-Leu-4]-OB3](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTM%2Fthumb-webp%2FT72906.webp&w=3840&q=75)
